Fatal leukemia in interleukin-15 transgenic mice

被引:36
|
作者
Fehniger, TA
Suzuki, K
VanDeusen, JB
Cooper, MA
Freud, AG
Caligiuri, MA
机构
[1] Ohio State Univ, Dept Internal Med, Div Hematol Oncol, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Div Human Canc Genet, Columbus, OH 43210 USA
[3] Ohio State Univ, Comphrehens Canc Ctr, Columbus, OH 43210 USA
[4] Gunma Univ, Sch Med, Dept Urol, Gunma, Japan
关键词
D O I
10.1006/bcmd.2001.0379
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The role of inflammation in the early genesis of certain malignancies has recently been appreciated. Interleukin (IL)-15, a proinflammatory cytokine and growth factor, is required for lymphocyte homeostasis. Intriguingly, the expression of IL-15 protein is tightly controlled by multiple posttranscriptional mechanisms, suggesting that inappropriate expression of IL-15 may be detrimental to the host. We recently engineered a transgenic mouse in which the normal posttranscriptional control of IL-15 is eliminated, thereby overexpressing the murine IL-15 protein. IL-15 transgenic mice have early expansions in NK and CD8(+) T lymphocytes and later develop fatal lymphocytic leukemia with a T-NK phenotype. This article recapitulates the phenotype of these IL-15 transgenic mice and discusses the utility of this model as a tool to further our understanding of leukemogenesis. (C) 2001 Academic Press.
引用
收藏
页码:223 / 230
页数:8
相关论文
共 50 条
  • [1] Adult T-cell leukemia cells express interleukin-15 receptor and proliferate in response to interleukin-15
    Yamada, Y
    Sugawara, K
    Tsuruta, K
    Maeda, T
    Tomonaga, M
    Kamihira, S
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 811 - 811
  • [2] Interleukin-15
    Cosman, D
    Kumaki, S
    Anderson, D
    Kennedy, M
    Eisenman, J
    Park, L
    IMMUNOLOGY, 1996, 89 : SF118 - SF118
  • [3] Fatal T/NK cell leukemia in IL-15 transgenic mice
    Fehniger, TA
    Suzuki, K
    Ponnappan, A
    VanDeusen, J
    Cooper, MA
    Robinson, M
    Durbin, J
    Caligiuri, MA
    FASEB JOURNAL, 2000, 14 (06): : A1024 - A1024
  • [4] Interleukin-15 responsiveness of interleukin-2 deficient mice.
    Lodolce, J
    Boone, D
    Dassopoulos, T
    Chai, S
    Trettin, S
    Ma, A
    GASTROENTEROLOGY, 1998, 114 (04) : A1024 - A1024
  • [5] Complementary Effects of Interleukin-15 and Alpha Interferon Induce Immunity in Hepatitis B Virus Transgenic Mice
    Di Scala, Marianna
    Otano, Itziar
    Gil-Farina, Irene
    Vanrell, Lucia
    Hommel, Mirja
    Olague, Cristina
    Vales, Africa
    Galarraga, Miguel
    Guembe, Laura
    Ortiz de Solorzano, Carlos
    Ghosh, Indrajit
    Maini, Mala K.
    Prieto, Jesus
    Gonzalez-Aseguinolaza, Gloria
    JOURNAL OF VIROLOGY, 2016, 90 (19) : 8563 - 8574
  • [6] The Role of Interleukin-15 Polymorphisms in Adult Acute Lymphoblastic Leukemia
    Lin, Dandan
    Liu, Chunliang
    Xue, Mengxing
    Liu, Rengyun
    Jiang, Lan
    Yu, Xiao
    Bao, Guangming
    Deng, Fang
    Yu, Mingjie
    Ao, Jiafu
    Zhou, Yifeng
    Wu, Depei
    Liu, Haiyan
    PLOS ONE, 2010, 5 (10):
  • [7] Interleukin-15 in autoimmunity
    Allard-Chamard, Hugues
    Mishra, Hemant K.
    Nandi, Madhuparna
    Mayhue, Marian
    Menendez, Alfredo
    Ilangumaran, Subburaj
    Ramanathan, Sheela
    CYTOKINE, 2020, 136
  • [8] Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases
    Waldmann, TA
    ARTHRITIS RESEARCH & THERAPY, 2004, 6 (04) : 174 - 177
  • [9] Serum and muscle interleukin-15 levels decrease in aging mice: Correlation with declines in soluble interleukin-15 receptor alpha expression
    Quinn, LeBris S.
    Anderson, Barbara G.
    Strait-Bodey, Lena
    Wolden-Hanson, Tami
    EXPERIMENTAL GERONTOLOGY, 2010, 45 (02) : 106 - 112
  • [10] Interleukin-15 interactions with interleukin-15 receptor complexes: Characterization and species specificity
    Eisenman, J
    Ahdieh, M
    Beers, C
    Brasel, K
    Kennedy, MK
    Le, T
    Bonnert, TP
    Paxton, RJ
    Park, LS
    CYTOKINE, 2002, 20 (03) : 121 - 129